All Biao He articles

  • Low-Res_37823-014
    News

    Intranasal COVID-19 vaccine headed to clinical trials

    2024-06-17T08:56:00Z

    CyanVac will sponsor a randomized, double-blind Phase 2b study to compare the efficacy and safety of CVXGA, its intranasal vaccine candidate designed to protect against COVID-19, against an FDA-approved mRNA-based COVID-19 vaccine.